Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jill Alldredge

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
2
2023
269
0.970
Why?
Endogenous Retroviruses
1
2023
37
0.730
Why?
Uterine Neoplasms
2
2021
96
0.730
Why?
Ovarian Neoplasms
3
2022
589
0.620
Why?
Papillomavirus Infections
1
2023
342
0.560
Why?
Germ-Line Mutation
1
2019
176
0.540
Why?
Genital Neoplasms, Female
1
2019
99
0.520
Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.520
Why?
B7-H1 Antigen
1
2019
242
0.510
Why?
Angiogenesis Inhibitors
1
2016
238
0.420
Why?
Neoplasm Recurrence, Local
2
2023
1145
0.410
Why?
Early Detection of Cancer
1
2019
472
0.400
Why?
Immunohistochemistry
2
2019
1705
0.220
Why?
Choriocarcinoma
1
2022
9
0.190
Why?
Endodermal Sinus Tumor
1
2022
10
0.190
Why?
Adenocarcinoma, Mucinous
1
2022
76
0.170
Why?
Neoplasms, Germ Cell and Embryonal
1
2022
76
0.170
Why?
Genetic Counseling
1
2019
81
0.140
Why?
DNA Mutational Analysis
1
2019
409
0.130
Why?
Cyclohexanes
1
2016
23
0.120
Why?
Survival Analysis
1
2019
1370
0.120
Why?
RNA
1
2023
926
0.120
Why?
Perineum
1
2016
37
0.120
Why?
Sesquiterpenes
1
2016
52
0.120
Why?
Genetic Testing
1
2019
480
0.120
Why?
Obstetric Labor Complications
1
2016
38
0.120
Why?
Metabolomics
1
2021
724
0.110
Why?
Lacerations
1
2016
40
0.110
Why?
Urinary Incontinence
1
2016
64
0.110
Why?
Neoplasm Staging
1
2019
1465
0.110
Why?
Bevacizumab
1
2016
168
0.110
Why?
Sexual Dysfunction, Physiological
1
2016
74
0.110
Why?
Female
7
2023
78304
0.100
Why?
Neoplasm Metastasis
1
2016
691
0.100
Why?
Clinical Trials as Topic
1
2016
1056
0.080
Why?
Genetic Predisposition to Disease
1
2019
2350
0.080
Why?
Humans
7
2023
144667
0.070
Why?
Prognosis
1
2016
4312
0.060
Why?
Middle Aged
3
2022
35971
0.050
Why?
Carcinoma, Endometrioid
1
2022
49
0.050
Why?
Carboplatin
1
2021
161
0.040
Why?
Paclitaxel
1
2021
256
0.040
Why?
Cisplatin
1
2021
339
0.040
Why?
Drug Resistance, Neoplasm
1
2021
881
0.030
Why?
Labor, Obstetric
1
2016
67
0.030
Why?
Fecal Incontinence
1
2016
90
0.030
Why?
Postpartum Period
1
2016
368
0.020
Why?
Adult
3
2022
40489
0.020
Why?
Young Adult
2
2021
14122
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1961
0.020
Why?
Aged, 80 and over
1
2021
8284
0.020
Why?
Prospective Studies
1
2016
7994
0.010
Why?
Surveys and Questionnaires
1
2016
6041
0.010
Why?
Pregnancy
1
2016
7122
0.010
Why?
Aged
1
2021
25955
0.010
Why?
Alldredge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)